loading page

Ferrimagnetic Vortex Nanorings Facilitate Efficient and Safe Deep-Brain Magnetothermal Stimulation in Freely Moving Mice
  • +8
  • galong Li,
  • Xin Qiao,
  • Yu Zhao,
  • Dongyan Li,
  • guigen Zhang,
  • Xiaoli Liu,
  • Fulin Chen,
  • Hongbin Lu,
  • Jin Zhou,
  • Changyong Wang,
  • Haiming Fan
galong Li
Northwest University
Author Profile
Xin Qiao
Beijing Institute of Basic Medical Sciences
Author Profile
Yu Zhao
University of Kentucky
Author Profile
Dongyan Li
Northwest University
Author Profile
guigen Zhang
University of Kentucky
Author Profile
Xiaoli Liu
Northwest University
Author Profile
Fulin Chen
Northwest University
Author Profile
Hongbin Lu
Air Force Medical University
Author Profile
Jin Zhou
Beijing Institute of Basic Medical Sciences
Author Profile
Changyong Wang
Beijing Institute of Basic Medical Sciences
Author Profile
Haiming Fan
Northwest University

Corresponding Author:fanhm@nwu.edu.cn

Author Profile

Abstract

Magnetothermal neuromodulation is a minimally-invasive, deep-brain accessible and tether-free technique. The precisely timed activation of thermosensitive ion channels, such as TRPV1, with local heat generated using magnetic nanoparticles is crucial for efficient neuromodulation. Nevertheless, this technique is greatly hindered by its long stimulus-response time and high safety risks due to the poor heat-generating performance of the nanomediators. Herein, we report the establishment of a ferrimagnetic vortex iron oxide nanoring (FVIO)-mediated magnetothermal neurostimulation technique that is efficient and safe. Compared with widely used superparamagnetic iron oxide nanomediators (SPIOs), the FVIOs triggered Ca2+ influx into HEK293T cells and cortical neurons at an Fe concentration of 54 μg/mL, which is 20.27-fold lower than that needed for SPIOs. In vivo magnetothermal stimulation in the central nucleus of the amygdala of mice further demonstrated that FVIOs with the optimal dose of 0.05 μg evoked fear behaviors with an average latency of 2.51 s, which was 2.3-fold faster than that in the SPIO (0.8 μg)-treated group. More importantly, FVIOs-mediated stimulation not only exhibited negligible histopathological alterations and proinflammatory cytokine expression, but also successfully elicited fear behaviors in transgene-free mice. The FVIO-mediated efficient and safe neuromodulation has the potential for future neuroscience exploitation and neurological disease treatment.
29 May 2024Submitted to Exploration
07 Jun 2024Reviewer(s) Assigned
10 Jul 2024Review(s) Completed, Editorial Evaluation Pending
27 Aug 2024Editorial Decision: Revise Major
12 Nov 20241st Revision Received